Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
182
datasets available to search
ShareScore release 0.9.0
Dataset results
182 results for “MSS”
Vorbipiprant (CR6086) / Balstilimab (AGEN2034) Combination in Stage IV Refractory pMMR - MSS CRC, and Other Metastatic GI Cancers
ClinicalTrials.gov study NCT05205330. IPD Sharing: NO. Countries: 1. Publications: 0.
FOLFOX and Bevacizumab in Combination With Botensilimab and Balstilimab (3B-FOLFOX) for the Treatment of Microsatellite Stable (MSS) Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT05627635. IPD Sharing: Not stated. Countries: 1. Publications: 0.
SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial
ClinicalTrials.gov study NCT04599140. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Long-course Chemoradiotherapy or Short-course Radiotherapy Combined With CAPOX, PD-1antibody, and COX-2 Inhibitor for MSS Locally Advanced Rectal Cancer (SERRAC)
ClinicalTrials.gov study NCT07150949. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fruquintinib Plus PD-1 Antibody in pMMR / MSS Locally Advanced Rectal Cancer (LARC) With High Immune Score
ClinicalTrials.gov study NCT04989855. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
ClinicalTrials.gov study NCT06589440. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon
ClinicalTrials.gov study NCT06567782. IPD Sharing: YES. Countries: 5. Publications: 0.
Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer
ClinicalTrials.gov study NCT06124378. IPD Sharing: NO. Countries: 1. Publications: 0.
The Combination of Immunotherapy and Neoadjuvant Chemoradiotherapy in MSS Locally Advanced Rectal Cancer
ClinicalTrials.gov study NCT04411537. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Patient-reported Outcomes (PRO) and Treatment Outcomes of Chinese Patients With MSS-type Advanced Colorectal Cancer Who Received the Zidovudine Combination Regimen in the Real World
ClinicalTrials.gov study NCT07105631. IPD Sharing: NO. Countries: 1. Publications: 0.
Exploratory Study on Combined Conversion Immunotherapy for Liver Metastasis of MSS Type Initial Unresectable Colorectal Cancer Based on Gene Status
ClinicalTrials.gov study NCT05409417. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study to Evaluate eFT508 Alone and in Combination With Avelumab in Subjects With MSS Colorectal Cancer
ClinicalTrials.gov study NCT03258398. IPD Sharing: NO. Countries: 1. Publications: 0.
Toripalimab Combined With Neoadjuvant Chemoradiotherapy as First-line Treatment for Locally Advanced，High-Risk，MSS Rectal Cancer
ClinicalTrials.gov study NCT05877573. IPD Sharing: NO. Countries: 1. Publications: 0.
A Clinical Study on the Efficacy and Safety of Fruquintinib in Combination With PD-1 Monoclonal Antibody and Chidamide in Refractory MSS Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT06979908. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Role of Gut Microbiota in Neoadjuvant Radioimmunotherapy for MSS, Locally Advanced Rectal Cancer
ClinicalTrials.gov study NCT06898359. IPD Sharing: NO. Countries: 1. Publications: 0.
Surgical Techniques in Diabetes Mellitus-II and Obesity. Metabolic Surgery Study (MSS)
ClinicalTrials.gov study NCT02310555. IPD Sharing: Not stated. Countries: 1. Publications: 0.
First-line Treatment of MCapOX + Cetuximab Vs. MFOLFOX6 + Cetuximab for RAS/BRAF Wild-type, MSS, Unresectable Left-Sided MCRC: a Multicenter, Randomized, Controlled, Phase III Study
ClinicalTrials.gov study NCT06616259. IPD Sharing: NO. Countries: 1. Publications: 0.
FMT+ QL1706+Bevacizumab+ XELOX as First-line Treatment for Advanced MSS-type Colon Cancer With Liver Metastasis
ClinicalTrials.gov study NCT06801665. IPD Sharing: NO. Countries: 1. Publications: 0.
Lvosidenib (AK112) Combined With CapeOX and Radiotherapy in Patients With Unresectable Metastatic MSS-type Colorectal Cancer
ClinicalTrials.gov study NCT06593548. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Single-center, Phase II Study on Efficacy & Safety of SCRT+CAPOX+Serplulimab+Bevacizumab for MSS Rectal Cancer
ClinicalTrials.gov study NCT07347951. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.